Drug Type Autologous CAR-T |
Synonyms 7X19-Themis, 7×19-THEMIS CAR-T Cell, 7×19-THEMIS CAR-T cells |
Target |
Action modulators |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Follicular Lymphoma | Phase 2 | China | 01 Sep 2026 | |
| Mantle-Cell Lymphoma | Phase 2 | China | 01 Sep 2026 | |
| Mediastinal large B-cell lymphoma | Phase 2 | China | 01 Sep 2026 |





